Agoracom Blog Home

Archive for the ‘Medical Marijuana Stocks’ Category

« Older Entries
Newer Entries »

Lexaria Announces Lower Prices for ViPovaTM Tea Due to Production Efficiencies

Posted by AGORACOM-JC at 8:28 AM on Tuesday, March 24th, 2015

Kelowna, British Columbia–(March 24, 2015) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) announces an immediate reduction in price for ViPovaTM CBD-infused tea from US$129 to US$99.

Efficiencies in the production process are allowing us to achieve lower costs, and those savings are being passed on to consumers. The lipid-infusion process is a patent-pending method used to bind the cannabidiol (CBD) with lipids for a more comforting and efficient experience.

Most competitors simply mix raw CBD contained with hemp oil into their edible products, but some studies have indicated that bioabsorption of CBD in this way is very poor. According to a story published February 27 byMainStreet, George Anastassov said “The compounds get destroyed by acid in the gastrointestinal tract, so there’s not much left of the benefits of CBD’s to be delivered to the blood stream. It’s not only about a product containing CBD’s but how much your body absorbs.”

ViPova’s patent-pending technology takes a little more time to incorporate into products than competitors who just add raw hemp oil, but in the last several months we have learned how to implement our techniques with greater efficiency and this has led to lower consumer prices.

The www.vipova.com website has already been changed to reflect the new pricing, and the coupon good for 30% off your second order remains in effect.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns.www.lexarienergy.com

About ViPovaTM

ViPovaTM uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPovaTM-branded tea. ViPovaTMuses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaTM has this ground-breaking technology for CBD/lipid infusion.www.vipova.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Announces Lower Prices for ViPovaTM Tea Due to Production Efficiencies

Private insurer covers medical marijuana costs

Posted by AGORACOM-JC at 11:18 AM on Monday, March 23rd, 2015

A university student’s medical marijuana is being paid for by his private insurance company – a feat some industry insiders say is unprecedented.

Sun Life Financial is covering the medical marijuana costs of University of Waterloo student Jonathan Zaid.

Peter Power / For The Toronto Star

Sun Life Financial is covering the medical marijuana costs of University of Waterloo student Jonathan Zaid.

By: Isabel Teotonio Living reporter, Published on Fri Mar 20 2015

After a hard-fought battle, Jonathan Zaid’s medical marijuana is being paid for by his private insurance company — a feat some industry insiders say is unprecedented.

Now, the third-year University of Waterloo student, who suffers from a rare illness called new daily persistent headache, is hoping this victory clears the way for other patients seeking coverage for cannabis.

“I had to fight a lot of battles to get to where I am,” says the 22-year-old Toronto native. “My persistence paid off in the end.”

Last summer, Zaid submitted a claim for his medical marijuana to insurance giant Sun Life Financial. It was denied. Insurance companies don’t typically pay for cannabis. Although medical marijuana is federally regulated it is not an approved medicine in Canada and has no Drug Identification Number (DIN).

But Zaid wouldn’t give up. He was frustrated with always asking his parents for money to buy his “medicine” from a licensed producer. And after trying 48 different drugs over the years, only marijuana eased his chronic headaches. He figured it should be recognized as prescription medication — after all, it was prescribed by a doctor.

Zaid, the son of a retired lawyer, presented research on his condition and the medicinal benefits of marijuana to an oversight committee of the University of Waterloo student union, which administers the student health plan. It would be up to the student association as the plan’s sponsor — that’s the organization or employer that sets up the healthcare plan — to ask Sun Life to make an exception.

Student Ben Balfour, who is part of the committee, says there was initial concern about approving Zaid’s request because it was their first time dealing with marijuana.

“We were testing the waters and we didn’t know how people would react,” says Balfour, vice-president of operations and finance for the Federation of Students.

But after much back and forth between Zaid and the committee, which includes a physician, his request was approved in December. The committee found Zaid’s evidence to be persuasive, that the plan could support the cost and that having Zaid’s medicinal marijuana covered would positively impact his academic success and wellbeing.

“It’s really something new and I was very excited to be a part of it,” says Balfour. “I’m just very glad that we were able to figure it all out in the end.”

Sun Life issued a cheque reimbursing Zaid for nearly $3,000, covering the costs of cannabis and a $750 vaporizer — he gave the money to his parents. His triumph doesn’t mean other U of W students are automatically covered for medicinal marijuana, which has not been added to the formulary. But, it opens the door for others to follow his lead and go through the same process.

Sun Life can’t comment on the specifics of this case or benefit plan. While medical marijuana is not an eligible expense in its standard benefit plans, Sun Life does consider requests for exceptions if directed by the organization or employer responsible for the benefit plan. Insurance behemoth Manulife has a similar policy, but is not aware of having made any exception for medical cannabis.

There are cases of the government paying for medical marijuana: Ontario’s Workplace Safety and Insurance Board (WSIB), Quebec’s Commission de la santé et de la sécurité du travail (CSST), and Veterans Affairs, via

Medavie Blue Cross, have covered cannabis costs.

It’s unclear how unusual Zaid’s case is because Sun Life will not comment on if other patients, or benefit plans, have requested similar coverage.

And, it’s unknown what effect, if any, it will have on future claims for cannabis made to insurers, says Wendy Hope, vice-president of external relations for the Canadian Life and Health Insurance Association. Hope says this sort of claim is not unprecedented and that some private insurers have, for some time now, been reimbursing costs for medical marijuana through health spending accounts – although it is rare.

Zaid attributes his success to not giving up, but realizes few patients have the strength, or know-how, to accomplish what he did.

“We’re talking about very sick people and lots of them don’t have the resources to spend in order to fight for fair access,” says Zaid. His advocacy work prompted him to launch the non-profit Canadians for Fair Access to Medical Marijuana and he now sits on the patient advisory board of licensed producer Bedrocan Canada.

Sarah Smith, who pays $180 a month out-of-pocket for medical cannabis after being denied by her private insurer, hopes Zaid’s case will impact insurance practices. Unlike Zaid, she says, “I didn’t have the fight in me.”

“I’m optimistic this will help open the eyes of insurance companies that not all prescriptions are pills, sometimes it’s an herb,” says Smith, not her real name. “They shouldn’t be differentiating — a prescription is a prescription.”

Zaid’s case is precedent-setting, says Marc Wayne, CEO of Bedrocan Canada and chair of the Canadian Medical Cannabis Industry Association.

“It’s an example of the way this type of thing has to work. . . Insurance companies aren’t going to come out and say, ‘We’re going to cover medicinal cannabis for everybody.’ It’s a case-by-case approach and hopefully it will reach a tipping point.”

Source: http://www.thestar.com/life/health_wellness/2015/03/20/private-insurer-covers-medical-marijuana-costs.html

Tags: , , , ,
Posted in Medical Marijuana Stocks | Comments Off on Private insurer covers medical marijuana costs

Lexaria Corp. to Present at Cannabis Investor Webcast

Posted by AGORACOM-JC at 9:10 AM on Wednesday, March 11th, 2015

KELOWNA, BC / March 11, 2015 / Lexaria Corp. (LXRP) (CSE: LXX) will be presenting at the Cannabis Investor Webcast on Thursday, March 12, 2015 at 11:00 AM ET.

“We’re excited that Lexaria Corp. has decided to present to our online audience of investors, analysts, executives, media, and consumers,” said Derwin A. Wallace, Senior VP of Investor Webcast. “The online interactive webcast will assist Lexaria Corp. in increasing its awareness and exposure.”

The Cannabis Investor Webcast will include presentations from privately-held and publicly-traded industry companies and industry professionals. Lexaria’s presentation will be 30-minutes long and followed by 15-minutes of Q&A. The Cannabis Investor Webcast is a great opportunity for the audience to research industry companies without taking time-off from work, paying registration fees and incurring travel-related expenses.

“The Cannabis Investor Webcast will provide Lexaria Corp, an online interactive platform that will give us an opportunity to provide an overview of our company and its recent developments to investors, media and the general public,” states Chris Bunka, President of Lexaria Corp.

Cannabis investors, analysts, executives, media, and consumers who would like to attend the free online webcast please click on the link http://www.cannawebcast.com/ and visit our Registration Page. To view the recording of the webcast please visit www.youtube.com and search for Cannabis Investor Webcast two weeks after the live presentation.

About Lexaria Corp.

Lexaria’s shares are quoted in the USA with the symbol LXRP and in Canada with the symbol LXX. The company searches for projects that could provide potential above-market returns.

To learn more about Lexaria Corp. visit www.lexariaenergy.com.

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that and cannabidiol-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). PoViva products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Tags: , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Corp. to Present at Cannabis Investor Webcast

Lexaria Discusses Launch of ViPova National Sales Initiative

Posted by AGORACOM-JC at 3:00 AM on Wednesday, February 25th, 2015

Lexaria is one of the most advanced and fastest growing companies within the exploding medical Marijuana Industry, one of the most recession-proof industry sectors without any apparent boom / bust cycle given North American demographics and the rapidly accelerating acceptance of medical marijuana.

Hub On AGORACOM / Corporate Website / Watch Interview

Tags: , , , , ,
Posted in All Recent Posts, Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Discusses Launch of ViPova National Sales Initiative

Lexaria Letter From the President

Posted by AGORACOM-JC at 8:09 AM on Tuesday, February 24th, 2015

Kelowna, British Columbia–(Newsfile Corp. – February 24, 2015) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) is pleased to provide a Letter From the President for all its stakeholders.

Lexaria has posted at its website www.lexariaenergy.com a letter from the president, outlining recent corporate activity and current and future business plans. The complete Letter from the President is also being filed with regulators in the USA and Canada, and sent directly to shareholders. A summary and excerpt from the letter follows.

I am pleased to offer this update on Lexaria Corp to all stakeholders, following many changes in the Company during the past year.

It is a particularly exciting time in the Company’s history. 2014 delivered the sharpest and most severe decline in oil prices in over 5 years, and one of the biggest declines of all time. In 2012 we quietly initiated efforts to maximize value from our Belmont Lake oil field through any means possible, including a complete asset sale.

The oil field was sold late in 2014. At a peak, we owed over $1.7 million to various creditors, much of this to management and directors who had provided significant loans to enable our operations. We are proud to have paid all these loans down to a zero balance and that every creditor was paid in full.

At our annual general meeting in 2014, you responded overwhelmingly in favor of our entry into the medical marijuana sector, and we have responded with vigor. We now have a joint venture that has applied to Health Canada, the governing body of the medical marijuana industry in Canada, for a license to produce 10,000 kg (approx 22,000 pounds) of medical marijuana per year. Lexaria owns 49% of that joint venture.

Meanwhile, we don’t want to either bet the entire company on a single license application; or ignore the much larger market for already-legal agricultural hemp products. It’s important to clearly understand our foray into the United States market: In the USA we do not sell cannabis and are not involved in the marijuana trade in any way, even in those states where it is legal to do so under state law.

We are proud to help people in their quest for health and wellness, and we have come to believe that CBD may play an integral role in general good health. As a publicly traded company we believe this is not only the more prudent path for our company to take on behalf of its investors, but also the more profitable one.

Having unveiled our www.vipova.com website and upon selling our first cup of tea, we became a national company able to sell our CBD infused tea – using patent-pending technology – anywhere in the United States.

In order to attempt to generate sales revenue, and with them, our expectations of eventual profits, we purchased 51% of PoViva Tea LLC and launched the ViPovaTM brand of Cannabidiol (CBD) infused teas. Of all the steps we’ve taken in guiding Lexaria forward over recent years, we are perhaps most excited about our entry into the CBD business. Lexaria is playing a leading role in this brand new industry by delivering CBD through our unique and distinctive lipid-infused process making it one of the most exciting emerging companies in the business today.

2015 will be a very busy year for us – we have a number of goals and initiatives.

Primary among these is to establish ViPovaTM as a widely recognized and trusted brand for delivering CBD using our patent pending process that we believe is more effective and comforting. As brand recognition grows we intend to broaden the brand with other products, such as flavored teas and coffee. ViPovaTM sales and product introductions will constantly be a focus during 2015.

We will also launch our second brand of products under the Lexaria Energy brand, keeping a smile on our corporate face as we use our original name for new purposes. Lexaria Energy will be launched in the first 6 months of 2015 as a line of nutritional supplements for active people, once again always using our patent pending technology to infuse CBD inside for comfort and effectiveness.

We expect our first product to be a CBD/Protein bar of exceptional quality and taste. We are hoping to make the Lexaria Energy Bar the only bar in the world that is low on the glycemic index; gluten-free; and incorporates CBD with our patent-pending technology. It is currently under development.

2014/2015 is a period of change for your company. We know we made the right move to back away from the oil and gas business, and the economics in that business have deteriorated even more rapidly than we feared they might. We have paid all our bills and debts so that the Company is not burdened or placed at risk. We’ve entered the medical marijuana business through a license application in Canada. And we are launching two new brands in the USA aimed at the exciting brand new fields of cannabidiol delivery.

Though there has been a lot of change, one thing in particular remains constant: our thanks to you our shareholders for your loyalty and steadfastness over the years. It is hard being a mouse among elephants but we’ve tried our best to work hard for you all the while we avoid being stepped on. Our commitment to you remains unchanged and we will work honestly and tirelessly on your behalf.

Sincerely,

Chris Bunka

President and CEO, Lexaria Corp .

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexarienergy.com

About ViPovaTM

ViPovaTM uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPovaTM-branded tea. ViPovaTM uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaTM has this ground-breaking technology for CBD/lipid infusion. www.vipova.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any planned corporate activity, business venture, or initiative will be pursued, or if pursued, will be successful. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on Lexaria Letter From the President

ViPova (TM) by Lexaria Launches National Sales Initiative

Posted by AGORACOM-JC at 8:06 AM on Monday, February 23rd, 2015

Kelowna, British Columbia–(February 23, 2015) – Lexaria, Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company”) announces that ViPovaTM by Lexaria has launched a national US initiative designed to assist Americans to simultaneously achieve two important objectives:

1) To try new ViPovaTM CBD-infused tea, hold a TEA PARTY in your home or office. The President of ViPova or another Lexaria/ViPova member will personally visit with you; share ViPovaTM Tea amongst the group; provide information; answer questions; and, invite participants to become Channel Partner Distributors.Contact ViPovaTM through our website or by email at [email protected], to make your request to host a ViPovaTM TEA PARTY. In order to qualify to host your TEA PARTY, certain criteria, not limited to the following, must be met: a minimum of 12 people over the age of 21 must attend the TEA PARTY. We will consider all TEA PARTY requests and follow up with you regarding possible dates and schedules, as we roam across the country.
2) Not only will TEA PARTY participants have a chance to enjoy great-tasting ViPovaTM tea with no obligation, they will also be able to apply on the spot at these unique events to become authorized CHANNEL PARTNER Distributors of ViPovaTM products. In addition to receiving extensive, industry leading product training, distributors will have the potential to earn an exciting supplementary income selling ViPovaTM products. Persons wishing to become ViPovaTM distributors can also apply by downloading an application form available at www.vipova.com A limited number of CHANNEL PARTNER distributorships will be available in each state in the country. Interested distributors or TEA PARTY hosts can also email us at [email protected] with your contact information and we will respond asap.

ViPovaTM by Lexaria is the country’s first CBD/Lipid-infused tea, and we are excited to launch this initiative to establish the nation’s best trained direct sales force for this highly anticipated brand launching.

Consumers across all 50 states can now buy America’s FIRST product that uses patent-pending technology to infuse CBDs within lipids for the most comforting and effective experience possible. As 2015 unfolds, ViPovaTM expects to offer additional products to its lineup.

As well, the Lexaria EnergyTM brand will also be launched in the first half of 2015 and ViPovaTM CHANNEL PARTNER Distributors will automatically be eligible to also sell the full line of Lexaria EnergyTM brand products as they are unveiled. Broadening our product offerings, combined with early geographic sales advantages, will make this opportunity to quickly acquire Distributor rights particularly rewarding.

The www.vipova.com website and our toll-free phone lines are taking tea orders. Customers can call 1-888-976-8482 from 9AM to 7PM EST Mon-Fri and we accept most major credit cards.

For a limited time only, our two introductory offers remain valid: on your first order, please enjoy free shipping and a coupon good for 30% off your subsequent order, regardless of order size.

About Lexaria

Lexaria’s shares are quoted in the USA with symbol LXRP and in Canada with symbol LXX. The company searches for projects that could provide potential above-market returns. www.lexarienergy.com

About ViPovaTM

ViPovaTM uses only legal CBD oil extracts, grown from legal hemp in locations where it is legal to do so, in ViPovaTM-branded tea. ViPovaTM uses its patent-pending process to infuse concentrated amounts of CBD within lipids in its tea, providing more bioactivity and comfort to the body during the absorption process. Only ViPovaTM has this ground-breaking technology for CBD/lipid infusion. www.vipova.com

FOR FURTHER INFORMATION PLEASE CONTACT:

Lexaria Corp.
Chris Bunka
Chairman & CEO
(250) 765-6424

FORWARD-LOOKING STATEMENTS

This release includes forward-looking statements. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements. Access to capital, or lack thereof, is a major risk and there is no assurance that the Company will be able to raise required working capital. Current oil and gas production rates may not be sustainable and targeted production rates may not occur. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation, managing and maintaining growth, the effect of adverse publicity, litigation, competition and other factors which may be identified from time to time in the Company’s public announcements and filings. There is no assurance that the medical marijuana, CBD sector, or alternative health businesses will provide any benefit to Lexaria, or that the Company will experience any growth through participation in these sectors. There is no assurance that existing capital is sufficient for the Company’s needs or that it will need to attempt to raise additional capital. There is no assurance that any cannabinoid-based product will promote, assist, or maintain any beneficial human health conditions whatsoever. No statement herein has been evaluated by the Food and Drug Administration (FDA). ViPovaTM products are not intended to diagnose, treat, cure or prevent any disease.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Lexaria Corp., Medical Marijuana Stocks | Comments Off on ViPova (TM) by Lexaria Launches National Sales Initiative

Enertopia Corporation Included in The Marijuana Index Leading Cannabis Related Index to Continually Supply Market Info and Analysis for Enertopia Corporation

Posted by AGORACOM-JC at 7:00 AM on Wednesday, February 18th, 2015

VANCOUVER, BC / February 18, 2015 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) announced today that it has been selected by The Marijuana Index (www.marijuanaindex.com) for inclusion in its MJIC Reporting Company Index.

The Marijuana Index is the leading equity tracking index featuring public companies involved in the legalized marijuana, cannabis and hemp sector. The Marijuana Index provides the most robust data set in the MMJ industry with a perpetually expanding assemblage of information available to brokers, analysts, investors and media.

For more information regarding Enertopia and its standing in The Marijuana Index please visit www.marijuanaindex.com.

“We are pleased to have Enertopia included in The Marijuana Index where our corporate story can be followed by a larger number of parties interested in our industry,” said President / CEO Robert McAllister of Enertopia. “As more companies enter this dynamic industry it is both a privilege and an opportunity to be tracked as a leading public company in the legal cannabis industry. This will allow our shareholders access to real-time industry data and an expansive set of tools to better follow our company and industry developments.”

“We view the inclusion of Enertopia in the Index as an important step in providing further legitimacy to public company legal cannabis operations,” stated Frank Marino, President of MJIC, Inc. “Investors in this quickly growing industry deserve and appreciate as much information as possible and we intend to continue to supply data and market intelligence for Enertopia in perpetuity.”

About The MJIC Marijuana Index

The MJIC Marijuana Index is the first and only Marijuana Sector Benchmark Index Series, measuring the combined performance of globally listed marijuana stocks. The Index series is calculated by using (Equal-Weight), providing a fair and balanced benchmark calculation methodology, for diverse stocks covered. The index provides existing and prospective investors with a targeted and centralized view of these pioneering securities which are positioned within a multi-billion dollar growth industry. Information and articles are shared from around the web on the business of marijuana as it unfolds throughout the United States and the world. The mission of The Marijuana Index is to become the centralized hub of communication between marijuana, cannabis, and hemp companies and the investment marketplace following the industry.

The Marijuana Index is the leading benchmark for tracking U.S. listed marijuana stocks as the first marijuana equity index of its kind.

To contact The MJIC Marijuana Index please visit: www.marijuanaindex.com or by email via [email protected]

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that inclusion into the MJIC Reporting Company Index will have any meaningful impact on the Company.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Posted in All Recent Posts, Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Corporation Included in The Marijuana Index Leading Cannabis Related Index to Continually Supply Market Info and Analysis for Enertopia Corporation

Clinical trials high on list for medical marijuana community

Posted by AGORACOM-JC at 2:42 PM on Tuesday, February 17th, 2015

The medical marijuana movement is asking the scientific community to make examining the therapeutic potential of cannabis in much more depth a priority, cannabis experts from North America and the UK declared on 14 February at the American Association for the Advancement of Science (AAAS) annual meeting in California. But the drug’s controlled status is continuing to slow efforts to investigate the myriad compounds in the plant.

The panellists said the evidence is clear that cannabinoids can treat different types of pain effectively. In addition, they cited some evidence that cannabinoids help with neurological conditions like epilepsy. There is also very early clinical trial data suggesting that the molecule cannabidiol (CBD) has an antipsychotic effect and some evidence that it could help with anxiety disorders.

Although cannabis use is associated with things like short-term memory loss and learning problems, the experts presented data showing that once use is stopped those effects disappear within a few days. They also said there is no proof of any long-term neurocognitive effects of chronic marijuana use on the adult brain, although there is some cause for concern about heavy use by adolescents.

The question of whether the compounds have untoward effects remains unclear due to insufficient research. The field is stalled because large clinical trials require the deep pockets of the pharmaceutical sector, but a major barrier is the lack of intellectual property around some of these compounds. ‘They are old drugs, they are hard to lock in patents, and that makes it difficult for someone to invest significantly into these kinds of research studies that might not have the long-term payback,’ explained Mark Ware, who runs the pain research unit at McGill University, Canada.

However, possession of cannabis is still illegal in most US states making it a difficult drug to work with in the clinic. Igor Grant, a neuropsychiatrist who directs the cannabis research centre at the University of California, San Diego, US, has conducted seven clinical trials that involved smoked or inhaled cannabis and all required that he obtain regulatory approvals from three separate agencies before he could even acquire the cannabis for the studies.

Research marijuana for the US is grown by University of Mississippi under government licence. Once investigators clear all of the approvals, they can request the study drug from the NIH in the form of cigarettes containing different concentrations of tetrahydrocannabinol or THC – the main psychoactive constituent of cannabis.

Cannabis in Canada

Cannabis research is far easier to pursue in Canada where there is a regulated government programme. The country controls cannabis differently to other drugs, arguing that it fits neither under natural health product regulations that govern the use of herbal medicines, nor under the pharmaceutical drug regulations.

Some of the Canadian companies that grow cannabis under licence are now funding clinical trials to try and develop a drug, according to Ware. ‘The money is out there, but the trick is to get these kinds of pilot studies – proof-of-concept studies – done that encourage people to do larger-scale trials,’ he said.

The experts agreed that more information is needed about therapeutic use of cannabis. To help fill this gap, the provincial ethics committee in Quebec recently directed that all patients cleared to use cannabis for medical reasons must agree to be part on an ongoing study. Ware has been tapped to help set up a Quebec-wide registry that will allow these patients to be tracked anonymously for adverse events, as well as for things like pain, spasticity, appetite level and mood. The registry is expected to go live by the end of March.

In the US, there has been much media and public interest in a strain of medical marijuana first developed to treat a child suffering from repeated seizures, dubbed Charlotte’s Web, which is high in CBD but does not contain any psychoactive compounds. But Ware is troubled by the phenomenon of parents and patients seeking out CBD therapeutics. ‘We don’t know where the cannabidiol is coming from; there is a tremendous kind of mythology about the stuff coming from eastern Europe or China,’ he said. Hemp farmers in Canada are being approached to produce CBD and are charging huge amounts of money, he added.

The development of such medicinal products is complicated by the fact that cannabis contains over 100 different ingredients that may be bioactive. This flies in the face of the model followed by regulatory agencies like the US Food and Drug Administration that are set up to deal with single molecules rather than complex mixtures.

Source: http://www.rsc.org/chemistryworld/2015/02/clinical-trials-high-list-medical-marijuana-community

Tags: , , , ,
Posted in Enertopia, Enertopia Corp., GrowPros Cannabis Inc., Lexaria Corp., Medical Marijuana Stocks, Next Gen, Supreme Pharmaceuticals Inc | Comments Off on Clinical trials high on list for medical marijuana community

Enertopia to Showcase V-LOVE(tm) for Women at Vancouver Wellness Show

Posted by AGORACOM-JC at 7:13 AM on Wednesday, February 11th, 2015

VANCOUVER, BC / February 11, 2015 / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce the launch of V-LoveTM for Women will be showcased at the upcoming Vancouver Wellness Show that will be held from Feb 13-15 at the Vancouver Convention Centre. This annual show offers the estimated 30,000 attendees various opportunities to learn and improve their quality of lives in such areas as good health, nutrition, physical and emotional wellbeing, women and wellness presentations.

Enertopia will be showcasing V-LoveTM. by handing out samples of V-LoveTM. and we invite all show attendees to drop by our booth #909 for further information.

Leading Women’s Health Expert Maureen McGrath will share the stage with media personality Fiona Forbes and author Lorna Vanderhaaghe to discuss Health and Personal Growth at 3:15 PM on Saturday Feb 14 and on Sunday Feb 15 at Noon, Maureen will be giving a presentation on “The Desire for Desire” in women sponsored by Enertopia.

Enertopia is also pleased to announce it has entered into an initial four month radio contract to create daily public awareness about Women’s sexual health by sponsoring the popular Sunday Night Sex Show on CKNW radio, with Maureen McGrath to raise awareness and continue to educate the public with her knowledge base and expertise in Women’s sexual health.

Maureen is a clinician in addition to being well known and sought after guest lecturer in the field of sexual health for men and women. She has a special interest in women’s sexual desire. This aligns with our vision for natural based healing options. Maureen’s passion over the past several years of learning and responding to her patient’s needs has led to natural based healing as a clear option for better health in many instances. She is in private practice both in North Vancouver and at Cross Roads Clinic in Vancouver where she see patients with sexual health issues.

“I am excited at the prospect of raising awareness and providing options about such an important subject as female and male sexuality, particularly the important issue of low sexual desire. Providing evidence-based strategies to patients is the cornerstone to getting people to feel comfortable discussing a subject that until now has been deemed taboo by many. Getting couples to live their life, their way is what this is all about,” said Maureen McGrath, RN and Sexpert.

For more information on the Vancouver Wellness Show please visit: Thewellnessshow.com/index.php or Enertopia.com

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that Maureen McGrath’s outreach or the V-LoveTM sexual gel will have any meaningful impact on the Company or the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia to Showcase V-LOVE(tm) for Women at Vancouver Wellness Show

Enertopia Announces V-LOVE ™ For Women

Posted by AGORACOM-JC at 8:07 AM on Monday, February 9th, 2015

VANCOUVER, BC / Enertopia Corporation (ENRT-OTCBB) (TOP-CSE) (the “Company” or “Enertopia”) is pleased to announce the launch of a new product line for women’s sexual health. This is the Company’s first step in its new initiatives and strategic plan in alternative health and wellness sector. V-LoveTM for Women is a desire gel and will be available for sale in Canada soon and will be available for sale in the USA later this year. The Company owns 100% of the product and how it will roll out the product to market.

The Company has entered into a partnership with Maureen McGrath, host of the popular Sunday Night Sex Show on CKNW radio, to raise awareness and continue to educate the public with her knowledge base and expertise in Men’s and Women’s sexual health. Maureen McGrath is a registered nurse in the field of sexual health for men and women.

Enertopia will be announcing additional information on its product lines and business plan in the immediate future as it launches its products in a growing sexual health market with industry sales that have surpassed $20 billion dollars and specifically over $1.2 billion dollars last year in the lubrication market alone. The first product launch V-Love will be in Canada and available in the United States in the coming months. The second product launch will be the V-LoveTM infused with CBD from industrial hemp oil made and only available in the USA. Our goal is to begin producing cash flows from these initiatives as soon as possible; focused on the immediate opportunities in the CBD-sectors derived from already-legal hemp. CBDs (Cannabidiols) have been found by many researchers to have antioxidant properties and are able to be infused into a number of products.

The US Federal government, through the US Department of Health and Human Services, owns US Patent #6,630,507, which among other things, claims that

“Cannabinoids have been found to have antioxidant properties, unrelated to NMDA receptor antagonism. This new found property makes cannabinoids useful in the treatment and prophylaxis of wide variety of oxidation associated diseases, such as ischemic, age-related, inflammatory and autoimmune diseases.”

Maureen is a clinician in addition to being well known and sought after guest lecturer in the field of sexual health for men and women. She has a special interest in women’s sexual desire. This aligns with our vision for natural based healing options. Maureen’s passion over the past two decades of learning and responding to her patient’s needs has led to natural based healing as a clear option for better health in many instances. She is in private practice both in North Vancouver and at Cross Roads Clinic in Vancouver where she see patients with sexual health issues.

“I am excited at the prospect of raising awareness and providing options about such an important subject as female and male sexuality. Providing evidence based strategies to patients is the cornerstone to getting people to feel comfortable discussing a subject that until now has been deemed very sensitive by many. Getting couples to live their life, their way is what this is all about,” said Maureen McGrath, RN and Sexpert.

During the Company’s research in the Medical Marijuana field and other parallel industries it has become apparent that proper education is paramount for people to regain their lives. “Everyone has to be their own personal advocate for better health.” Stated President / CEO Robert McAllister

For further information please visit the company’s updated website www.enertopia.com that has incorporated today’s news and the new Health Canada guidelines for Licensed Producers and those in the process of becoming a licensed producer on what can be shown on one’s website or printed materials.

About Enertopia

Enertopia’s shares are quoted in Canada with symbol TOP and in the United States with symbol ENRT. For additional information, please visit www.enertopia.com or call Robert McAllister, the President: (250) 765-6412

This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements which are not historical facts are forward-looking statements. The Company makes forward-looking public statements concerning its expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, potential and financing of its medical marihuana projects, evaluation and sale of sexual creams and other items, competitive positions, growth opportunities, plans and objectives of management for future operations, including statements that include words such as “anticipate,” “if,” “believe,” “plan,” “estimate,” “expect,” “intend,” “may,” “could,” “should,” “will,” and other similar expressions that are forward-looking statements. Such forward-looking statements are estimates reflecting the Company’s best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that other factors will not affect the accuracy of such forward-looking statements., foreign exchange and other financial markets; changes of the interest rates on borrowings; hedging activities; changes in commodity prices; changes in the investments and exploration expenditure levels; litigation; legislation; environmental, judicial, regulatory, political and competitive developments in areas in which Enertopia Corporation operates. The User should refer to the risk disclosures set out in the periodic reports and other disclosure documents filed by Enertopia Corporation from time to time with regulatory authorities. There is no assurance that Maureen McGrath’s outreach or the V-LoveTM sexual gel will have any meaningful impact on the Company or the Company will be able to obtain future financings.

The CSE has not reviewed and does not accept responsibility for the adequacy or accuracy of this release

Start your small cap medical marijuana research in the AGORACOM Small Cap 
Medical Marijuana Stocks Gateway: 
http://agoracom.com/portal/Small%20Cap%20Medical%20Marijuana%20Stocks

Tags: , , , , ,
Posted in Enertopia, Enertopia Corp., Medical Marijuana Stocks | Comments Off on Enertopia Announces V-LOVE ™ For Women

« Older Entries
Newer Entries »